Eledon Pharmaceuticals, Inc. (ELDN) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $81.00K; Additional Paid in Capital, Common StockUSD $504.90M; Additional Paid in Capital, Preferred StockUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-114.00K.
- 2026-03-31: Common Stock, Value, IssuedUSD $76.00K; Additional Paid in Capital, Common StockUSD $484.99M; Additional Paid in Capital, Preferred StockUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-72.00K.
- 2025-12-31: Common Stock, Value, IssuedUSD $75.00K; Additional Paid in Capital, Common StockUSD $482.19M; Additional Paid in Capital, Preferred StockUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $24.00K.
- 2025-09-30: Common Stock, Value, IssuedUSD $60.00K; Additional Paid in Capital, Common StockUSD $426.05M; Additional Paid in Capital, Preferred StockUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $9.00K.
Eledon Pharmaceuticals, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Additional Paid in Capital, Preferred Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | Additional Paid in Capital USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $81.00K | $504.90M | (m) | $-114.00K | $-471.86M | $33.01M | 3 month · $3.15M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $76.00K | $484.99M | (m) | $-72.00K | $-440.23M | $44.76M | 3 month · $2.20M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $75.00K | $482.19M | (m) | $24.00K | $-401.20M | $81.08M | 12 month · $10.45M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $60.00K | $426.05M | (m) | $9.00K | $-390.76M | $35.36M | 3 month · $2.43M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $60.00K | $423.62M | (m) | $-48.00K | $-373.30M | $50.33M | 3 month · $2.69M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $60.00K | $420.93M | $420.93M | $-18.00K | $-362.08M | $58.89M | 3 month · $2.86M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $60.00K | $417.95M | $417.95M | $26.00K | $-355.59M | $62.45M | 12 month · $13.12M | (m) | (m) | (m) | (m) |
| 2024-09-30 | $41.00K | $331.19M | $331.19M | $102.00K | $-310.97M | $20.36M | 3 month · $1.78M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $39.00K | $323.71M | $323.71M | (m) | $-387.94M | $-64.19M | 3 month · $3.06M | (m) | (m) | (m) | (m) |
| 2024-03-31 | $25.00K | $328.28M | $272.59M | (m) | $-343.03M | $-70.42M | 3 month · $1.69M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $24.00K | $270.89M | $270.89M | (m) | $-319.40M | $-48.49M | 12 month · $6.54M | (m) | (m) | (m) | (m) |
| 2023-09-30 | $24.00K | $324.88M | (m) | (m) | $-289.30M | $35.60M | 3 month · $1.73M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $23.00K | $323.14M | (m) | (m) | $-279.40M | $43.77M | 3 month · $1.72M | (m) | (m) | (m) | (m) |
| 2023-03-31 | $14.00K | $288.42M | (m) | (m) | $-213.64M | $74.79M | 3 month · $1.38M | (m) | (m) | (m) | (m) |
| 2022-12-31 | $14.00K | $287.03M | (m) | (m) | $-202.87M | $23.79M | 12 month · $8.15M | (m) | (m) | (m) | (m) |
| 2022-09-30 | $14.00K | $285.56M | (m) | (m) | $-144.48M | $141.09M | 3 month · $2.19M 9 month · $6.68M | (m) | (m) | (m) | (m) |
| 2022-06-30 | $14.00K | $283.38M | (m) | (m) | $-134.01M | $149.38M | 3 month · $2.31M 6 month · $4.49M | (m) | (m) | (m) | (m) |
| 2022-03-31 | $14.00K | $281.07M | (m) | (m) | $-124.76M | $156.32M | 3 month · $2.19M | (m) | (m) | (m) | (m) |
| 2021-12-31 | $14.00K | $278.88M | (m) | (m) | $-114.90M | $164.00M | 12 month · $7.90M | (m) | (m) | (m) | (m) |
| 2021-09-30 | $14.00K | $276.83M | (m) | (m) | $-106.09M | $170.75M | 3 month · $2.04M 9 month · $5.85M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $14.00K | $274.78M | (m) | (m) | $-96.28M | $178.52M | 3 month · $2.03M 6 month · $3.81M | (m) | (m) | (m) | (m) |
| 2021-03-31 | $14.00K | $272.75M | (m) | (m) | $-88.89M | $183.87M | 3 month · $1.77M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $15.00K | $270.97M | (m) | (m) | $-80.39M | $190.60M | 12 month · $3.17M | (m) | (m) | (m) | (m) |
| 2020-09-30 | $1.00K | $95.99M | (m) | (m) | $-74.49M | $21.51M | 3 month · $878.00K 9 month · $1.51M | (m) | (m) | (m) | (m) |
| 2020-06-30 | $19.00K | $77.68M | (m) | (m) | $-68.34M | $9.36M | 3 month · $197.00K 6 month · $634.00K | (m) | (m) | (m) | (m) |
| 2020-03-31 | $16.00K | $77.49M | (m) | (m) | $-65.76M | $11.74M | 3 month · $437.00K | (m) | (m) | (m) | (m) |
| 2019-12-31 | $1.00K | $67.05M | (m) | (m) | $-57.58M | $9.46M | 12 month · $1.31M | (m) | (m) | (m) | (m) |
| 2019-09-30 | $13.00K | $66.79M | (m) | (m) | $-53.44M | $13.37M | 3 month · $227.00K 9 month · $1.06M | (m) | (m) | (m) | (m) |
| 2019-06-30 | $13.00K | $66.56M | (m) | (m) | $-50.55M | $16.03M | 3 month · $627.00K 6 month · $838.00K | (m) | (m) | (m) | (m) |
| 2019-03-31 | $9.00K | $56.37M | (m) | (m) | $-46.45M | $9.93M | 3 month · $211.00K | (m) | (m) | (m) | (m) |
| 2018-12-31 | $9.00K | $56.05M | (m) | (m) | $-41.57M | $14.49M | 12 month · $1.54M | (m) | (m) | (m) | (m) |
| 2018-09-30 | $9.00K | $55.31M | (m) | (m) | $-37.00M | $18.32M | 3 month · $237.00K 9 month · $802.00K | (m) | (m) | (m) | (m) |
| 2018-06-30 | $9.00K | $55.01M | (m) | (m) | $-33.50M | $21.51M | 3 month · $404.00K 6 month · $565.00K | (m) | (m) | (m) | (m) |
| 2018-03-31 | $9.00K | $54.60M | (m) | (m) | $-30.31M | $24.30M | 3 month · $161.00K | (m) | (m) | (m) | (m) |
| 2017-12-31 | $7.00K | $46.95M | $0.00 | (m) | $-27.51M | $19.45M | 12 month · $579.00K | (m) | (m) | (m) | (m) |
| 2017-09-30 | $7.00K | $46.01M | (m) | (m) | $-25.40M | $20.62M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $7.00K | $45.86M | (m) | (m) | $-22.43M | $23.44M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $23.00K | $196.60M | (m) | (m) | $-173.26M | $23.36M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $1.00K | $11.38M | $291.00K | $-1.00K | $-14.39M | $-2.70M | 12 month · $171.00K | $19.00K | (m) | (m) | 12 month · $1.40M |
| 2016-09-30 | $23.00K | $195.89M | (m) | $3.00K | $-165.66M | $30.26M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $23.00K | $195.25M | (m) | $6.00K | $-156.39M | $38.88M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $23.00K | $194.25M | (m) | $-5.00K | $-142.86M | $51.41M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $23.00K | $193.19M | (m) | $-55.00K | $-131.44M | $2.78M | 12 month · $2.90M | (m) | (m) | (m) | 12 month · $1.40M |
| 2015-09-30 | $23.00K | $192.29M | (m) | $8.00K | $-120.42M | $71.90M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $22.00K | $191.30M | (m) | $-2.00K | $-108.57M | $82.75M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $22.00K | (m) | (m) | (m) | $-99.61M | $90.90M | (m) | (m) | $190.49M | (m) | (m) |
| 2014-12-31 | $22.00K | $189.83M | (m) | (m) | $-86.35M | $103.50M | 12 month · $2.11M | $0.00 | $189.83M | 12 month · $3.33M | (m) |
| 2014-09-30 | $22.00K | (m) | (m) | (m) | $-80.14M | $101.61M | (m) | (m) | $181.73M | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $-63.05M | $-55.27M | 12 month · $238.00K | $0.00 | $7.79M | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | $-39.90M | 12 month · $210.00K | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | $-30.43M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |